{"name":"4D pharma plc","slug":"4d-pharma-plc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Blautix","genericName":"Blautix","slug":"blautix","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Blautix","genericName":"Blautix","slug":"blautix","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizAJBVV95cUxOa3M0UlRnRDJDclo5c0lDYXd0MVNTSkpTZmNOUkl3MDEyZEk4anRzallJSzBfb2R0a28wRnFoVWYyM2tNVVEyS0tVNWczY1RXSWl0Q0JQeVZBNmRZNzJYZk5FRC16cUFvQWxXV0tSaXJfUE8xTElyRDc0SXJ4QkppY3JINVpQVURrM2dJcnVjVjdGQnp6M3NyUmctXzczbTVDNk5pbEhSeWQzelBTQ2dyb3VwZG8tbWtIV1JJUTg1aURZM0d6VXo3YzNrNm03a2IxazFDQ2JqSm0yNWVXU1dySnpKUG5iekFyalFYNDl2TE5sZXRBSWt5aDQyZFhaOUx0cXRvYk5JbXI5bmVGU1JsTkhmU2ZNbjJxNFNIVE1JUndiQ2g4aXZHaXVMSE1acjFDQVFXYThTOWFJNjBtWlZHQVVGRG5lWHJQcERaRQ?oc=5","date":"2026-03-31","type":"trial","source":"Barchart.com","summary":"Urothelial Carcinoma Clinical Trial Pipeline Expands as 40+ Pharma Companies Progress 50+ Novel Therapies Toward Market Entry, Finds DelveInsight | Janssen Research and Development, MedPacto - Barchar","headline":"Urothelial Carcinoma Clinical Trial Pipeline Expands as 40+ Pharma Companies Progress 50+ Novel Therapies Toward Market ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxQbkk4RVM2cUo5VGtyaWdnc3RMSG53bUlMbEtNb2dyZHcwWEd1M3BJaGIzclhvTzFhLUJXQlJlRXpLLS15bWN5MkRWMXE4YzNxX00tZEk5ZGp2ZWtkdUduUHV0eE9wY0p0Sm5DYzZNTHd4QjdWdS1lTU5UMVo3U0tKUEl4eE5DcmhkbXhXbGRMbmxXOFN0aVJXUl9wVlRwdTJfTnMzU1hoT0VBTG4xeFA3WW1UOFJNTEJ1VEpJMmFPNlN6SDBFWXJ0bGQwN0lRaDYxX2tQZl9XOXJ6ZGp4U3Vpby1mUDhmMzFrbVMwU01ycnlWZEh3NkVMSTN6SkEyc2lzRnpKeUVFSDRRc3N1WjV1WWxKOERXSkI1cmxjVmh0VndTWjRuTmNqM095cW1Jc2pVcUFRRkU4TGFjOXN3UlBianctbUxfb1NhMWF5Z1BR?oc=5","date":"2026-03-26","type":"pipeline","source":"Barchart.com","summary":"Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma - B","headline":"Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia The","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxQWTJVTGh0ejN2YjM1TlN0dzlINUI2X0dubnVSWHdzTGxaZFBRM3RqNm14LWdMWERyamxIbW1YTHZLRWhpbDhDR3dFNHIwSWxMWGZOQXBweEpPdG9qakYwNUoySzZZN0lQQlV2a1FDX0Z0ZmxDYlREY0tmSVpYYkR6YjY4OWlseUFTWmF3VG1fMElGeXNTczZsTEFFdFpOTy1JN3ZJMnd5NGFTNXpaeXRINnNkWVBTVW1zbUlwZGNROUZnR0xvcXpLcFh1dXdmMEFMUGJYU2dMNV9Zdm9VcktZMUU4WUQzZmxrcEdqVXRQT1RtbWhlS1NZYTk0WmVqWUdZakhvZGIwaVdMVU84MDAyNkVZOFhlNkRFODR5T2ZzTzQzOWpPMjF0cktlcDVZNl9Nc0hkbWc5ZldWZm1iSlVNaWx3aURiWF9lUnc?oc=5","date":"2026-03-26","type":"pipeline","source":"Barchart.com","summary":"Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma - B","headline":"Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia The","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE5fZnpBS054a2hJRXM2TWJISkhoMERzYmlGcGFxdFIyNUZ3bDZjam9FV254QkU5WlZmZExsQ0dFN1NXaFJTeFROLTM2T0czWDhOR09KMktaZnVwTVdkamlrNTN2NTRfZEduU2s0UDNzakh5UUhodzZlb21maVlHUQ?oc=5","date":"2025-03-26","type":"pipeline","source":"Pharmaceutical Technology","summary":"MSD enters agreement with Hengrui Pharma for Lp(a) inhibitor - Pharmaceutical Technology","headline":"MSD enters agreement with Hengrui Pharma for Lp(a) inhibitor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxQUlBEN2JQMkVlejVsUDE0d0pQcXhDTHBHdE1nMmhzTVNERFBfTDkzWW83Yi1ZZEpBbHowUjA1S0VpNnJ2NXZnUHRJY09NUDVxZnp2WFNxc1I2Q0x3dTFldXhFNm5JUDR5MlA4a0tDeTUxYm5WYTZMVzZUczJHYjBHbDFFaDRiTDZTSlJNRzFnbHBjNUYwNkR3ejJGa3AweDlpeVdhdk5ucGJmSHctSTdHS3g5N2lMYU1fMDB3TlYtUlBScG4zYUI4bk5LQjVlaGt3blZ5OWRfdkVCY2NFcWYtZ1UxVGxrZWJtZExQSGxFYUN4c1ZSQWhaZkxhT1M1RXRudlNuRXNlMXQ3MzFPMkZTeFRvS3VVaHprWlpsazd1akZOUQ?oc=5","date":"2024-11-06","type":"trial","source":"prnewswire.com","summary":"Severe Asthma Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - prnewswire.com","headline":"Severe Asthma Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively Working in the Therapeutics ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE50dVF6NlR0Vm5QNkFuUUg3OHZ2dW1BQTg2NHFkUDZKVDdWV3JuUHN4MlhvQVhXbnRTdkF1LWRhWHZERUFaQkxNZnRfYTJBOGpMcUFrNGFwTkFuekFjSER4TnBHSmpFMTEzQW8zLXNR?oc=5","date":"2023-03-27","type":"deal","source":"KED Global","summary":"Korea's CJ Bioscience buys drug candidates from 4D pharma of the UK - KED Global","headline":"Korea's CJ Bioscience buys drug candidates from 4D pharma of the UK","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOaWFrR1JqTVdheHJUTVFtbm8zaFNLcVdQQ2JxRXVBME1VTTVyY1BiaFdIdWNFYzFJTXBnUU1IQjAwYnpQMjJENlYtQVNSVUlYVTktSzdxU1JuR0c5ODdSTVZpYW9Sel9UY3ljaktzY2x6MmpRMm0xckYtTXY0Qk11VWFxLW9VUQ?oc=5","date":"2023-02-16","type":"pipeline","source":"Insider Media Ltd","summary":"4D Pharma shares cancelled from AIM - Insider Media Ltd","headline":"4D Pharma shares cancelled from AIM","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNdURkeG1DQS1yYTBxeGR5RFFlMFh6X085T2JpV0V0VGVzUE9GOU1HTjVDMXA0MUlsU0xfcFhWa2FYNnhsVEpHemVlU3lIRzhMamREaEtjZWxEb3YzV2REUlc5Y0pSR0lMRVpNa1hZZ05FbWRSM18xWFpYQUNaNjlIYnlJRzh0dXpLTjhVOERMaTIxcWZyOUxTZQ?oc=5","date":"2023-02-15","type":"pipeline","source":"Share Talk","summary":"4d Pharma PLC (AIM:DDDD) Cancellation of admission to trading on AIM - Share Talk","headline":"4d Pharma PLC (AIM:DDDD) Cancellation of admission to trading on AIM","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE1JcHlrSThiamtzUERXZnFoeUlFM2c0a18tRGljSGVoM0hzZm1PbVgtZW9TZl9RTXZBaTlNbnBRUDZLUGxYUFdXSzR4S3lZeW9Xdm5ZaFJUMUtRTmVRUkIwY3lsWQ?oc=5","date":"2022-11-11","type":"trial","source":"Wiley Online Library","summary":"Randomised clinical trial: efficacy and safety of the live biotherapeutic product MRx1234 in patients with irritable bowel syndrome - Wiley Online Library","headline":"Randomised clinical trial: efficacy and safety of the live biotherapeutic product MRx1234 in patients with irritable bow","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE80YVVBNkdYZnhmalowaEdWSEs0Ykl2elhDbV9zVUNSQ3hFX3pfMmRBU1F3M2ZxMkgzMDJ4bUNfTnYwZlljX1NxN0pTX1RCVmJrM1N6N0FTeXo0aDl0ajRDS1FrYU52MWdtZDNPWjRqOXB5TFZSODhz?oc=5","date":"2022-01-21","type":"pipeline","source":"Yahoo Finance","summary":"How Much Of 4D pharma plc (LON:DDDD) Do Insiders Own? - Yahoo Finance","headline":"How Much Of 4D pharma plc (LON:DDDD) Do Insiders Own?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxQREQ5eklHdEczVE9DYVY1YTVpSFVnSXdoMVMwaU9pcDBWakV4SWR0SE5veThVcHBmQ2xYM3p4eWhzUW9mM1plWXplWjFPc3NyMTJQNGprTy1mNXhWWmQySHN2TXpZU3g5am1nZV9uQ2VzY2F4Y2hDUmtGaFk2bmVBTTBpUkdMQWREMU5mMmh3Z2ExblJFSFg2bVViSjhWeVRRNUtFbmZ4cTJXa3FRVU1GOWVnUWlnOFNjVHFsSzZiT29DakpGUGJqc0M5VTc?oc=5","date":"2021-03-29","type":"deal","source":"Wilson Sonsini","summary":"Firm Advises 4D pharma on Merger with Longevity Acquisition Corporation and Nasdaq ADS Listing - Wilson Sonsini","headline":"Firm Advises 4D pharma on Merger with Longevity Acquisition Corporation and Nasdaq ADS Listing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBwNDV1cFhXSWtydFFHYVlDcWRlSDBPTFFUeDdDaGJvMEx3cHZIbmhkNVl4WTY1SDBHNzRyQ2RuTHlHUEZMbHYwSkFTRG1DNzJaSkJuTGJ4WVh6YWw5VFVB?oc=5","date":"2020-09-01","type":"pipeline","source":"Nature","summary":"Revolutionary new medicines from the human gut microbiome - Nature","headline":"Revolutionary new medicines from the human gut microbiome","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}